Allianz Asset Management
MIRM icon

Allianz Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Allianz Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.89M Buy
31,255
+3,811
+14% +$359K ﹤0.01% 1413
2025
Q4 		$2.17M Buy
27,444
+24,644
+880% +$1.77M ﹤0.01% 1514
2025
Q3 		$205K Buy
+2,800
New +$178K ﹤0.01% 1952
2025
Q2 		– Sell
-6,500
Closed -$293K – 2187
2025
Q1 		$293K Buy
6,500
+700
+12% +$33K ﹤0.01% 2048
2024
Q4 		$240K Buy
+5,800
New +$242K ﹤0.01% 2066

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Allianz Asset Management's MIRM Position: Q1 2026 in Review

Allianz Asset Management increased its Mirum Pharmaceuticals (MIRM) stake by 14% in Q1 2026, buying an estimated $359K and bringing the position to 31,255 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1413.

Allianz Asset Management first reported a position in MIRM in Q4 2024 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Allianz Asset Management held 31,255 shares of Mirum Pharmaceuticals worth $2.89M as of Q1 2026.
  • Allianz Asset Management bought 3,811 Mirum Pharmaceuticals shares in Q1 2026, an estimated $359K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1413 holding.
  • Allianz Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.